Turnabout is fair playfor bone densitometry firm Hologic. The Waltham, MA, company raisedthe stakes this month in its legal battle with Lunar, filing acountersuit that accuses its competitor of infringing on its patents.The suit seeks to have three Lunar
Turnabout is fair playfor bone densitometry firm Hologic. The Waltham, MA, company raisedthe stakes this month in its legal battle with Lunar, filing acountersuit that accuses its competitor of infringing on its patents.The suit seeks to have three Lunar patents invalidated.
Lunar, of Madison, WI, fired the opening salvo last month whenit filed a federal lawsuit in U.S. District Court for the EasternDistrict of Wisconsin (SCAN 9/14/94). Lunar said that Hologic'smorphometry process is covered by three Lunar patents and askedthe court to overturn several Hologic patents.
Hologic's countersuit, filed in U.S. District Court for theDistrict of Massachusetts, charges that Lunar is infringing ontwo of Hologic's patents and asks for injunctive relief and damages.The complaint also seeks a declaration that Hologic does not infringeon three Lunar patents, which should be invalidated, accordingto the company. Finally, Hologic is asking for injunctive reliefand damages in connection with what the company said was "Lunar'sdissemination of false and misleading information which misrepresentsand disparages the quality of Hologic's bone densitometry products."
Seven Takeaways from New CT and MRI Guidelines for Ovarian Cancer Staging
January 20th 2025In an update of previous guidelines from the European Society of Urogenital Radiology published in 2010, a 21-expert panel offered consensus recommendations on the utility of CT, MRI and PET-CT in the staging and follow-up imaging for patients with ovarian cancer.
Four Strategies to Address the Tipping Point in Radiology
January 17th 2025In order to flip the script on the impact of the radiology workforce shortage, radiology groups and practices need to make sound investments in technologies and leverage partnerships to mitigate gaps in coverage and maximize workflow efficiencies.
CT Study Reveals Key Indicators for Angiolymphatic Invasion in Non-Small Cell Lung Cancer
January 15th 2025In computed tomography (CT) scans for patients with solid non-small cell lung cancer (NSCLC) < 30 mm, emerging research suggests the lollipop sign is associated with a greater than fourfold likelihood of angiolymphatic invasion.